Former Chairman and CEO, Johnson & Johnson

Chairman of the Board and Chief Executive Officer

Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants

Johnson &amp; Johnson price target raised by $21 at Bernstein, here's why

Prostate Cancer Hormone Therapy Market to Reach US$ 79.89 Bn by 2032, Reports Persistence Market Research

Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Associate Director, Medical Science Liaison, Cardiac Electrophysiology

Johnson & Johnson is a leader in healthcare innovation, committed to improving health outcomes through advanced medical solutions. The Associate Director, Medical Science Liaison will engage with key opinion leaders and healthcare professionals in the field of cardiovascular medicine, focusing on KOL engagement, research, and education to bridge the gap between the company and its customers in cardiac electrophysiology.

Associate Director, Medial Science Liaison, Cardiac Electrophysiology (1 of 6)

Vice President, Clinical Development & Scientific Affairs, Interventional Oncology

Associate Director, Clinical Sciences

Director, Clinical Development Strategy Implementation Lead; Immunology

Director, Senior Clinical Scientist Group Lead, Ophthalmology

Medical Director, Clinical Research (Oncology CAR-T Cell Therapy)

Sign up with Google

Sign in with Google